Falloon
Alan Edward Falloon, Beckwith CA
Patent application number | Description | Published |
---|---|---|
20150363602 | SYSTEM AND METHOD FOR ACCESSING AND UPDATING SECURED DATA - A method is provided for use on an electronic device having a display, a communication component, a memory, and a processor coupled to the display, the communication component, and the memory. The memory stores data in a first sandbox and data in a second sandbox, the first sandbox being a secure sandbox and having a shadow data component, the shadow data component storing a subset of the data stored in the first sandbox. The method comprises, in response to a request, providing the data stored in the first sandbox when the first sandbox is in an unlocked mode and providing the data stored in the shadow data component when the first sandbox is in a locked mode. | 12-17-2015 |
Elizabeth Falloon, Bethesda, MD US
Patent application number | Description | Published |
---|---|---|
20130065781 | GENE SETS FOR DETECTION OF ULTRAVIOLET A EXPOSURE AND METHODS OF USE THEREOF - Ultraviolet radiation (UVR) has profound effects on human skin. However, its effects on the global transcriptome in vivo have not been well characterized. In addition, the contribution of the UVA component of UVR has not been previously assessed in vivo. Disclosed herein is the identification of sets of genes that are either up-regulated or down-regulated in response to UVA exposure. The gene sets described herein can be used to accurately identify skin samples that have been exposed to UVA and to assess the ability of a sun protection product to block the effects of UVA. | 03-14-2013 |
Patrick Falloon, Cambridge, MA US
Patent application number | Description | Published |
---|---|---|
20150284371 | HETEROCYCLE-BISAMIDE INHIBITORS OF SCAVENGER RECEPTOR BI - This application describes compounds and methods that can inhibit Scavenger receptor class B, type I (SR-BI) activity, which compounds and methods can be used, for example, to mediate high-density lipoprotein (HDL) lipid uptake and treat hepatitis C viral infections. The compounds have the formula: wherein R | 10-08-2015 |